Corteva, Inc. (CTVA) Stock Price & Analysis
Corteva, Inc. (CTVA) closed at USD 12.86 on Thursday, October 22, 2026, up 1.10% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 12.86; the Oct 22, 2026 session ranged USD 12.52–12.89 on volume of 16,000,948 shares. Market capitalization is —, with a 52-week range of USD 9.08–14.62 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CTVA.md
Key facts (CTVA)
- Last four reported quarters (through Jun 30, 2026): revenue $17.8B, net income $1.01B (5.7% margin), free cash flow $629M (SEC filings).
- 2 of 80 tracked superinvestors hold CTVA (13F, Q2 2026): 0 new, 0 added, 2 reduced, 0 unchanged.
- Total return with dividends: 1Y +36.3% vs S&P 500 +14.9%; 5Y +111.5% vs S&P 500 +80.3%.
- Next earnings: 2026-11-11, EPS estimate USD 0.11, revenue estimate $1.76B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CTVA)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $15.7B | $17.5B | $17.2B | $16.9B | $17.4B | $17.8B |
| Gross profit | $6.43B | $7.02B | $7.31B | $7.38B | $8.23B | — |
| Net income | $1.76B | $1.15B | $735M | $907M | $1.09B | $1.01B |
| EPS (diluted) | $0.36 | $0.24 | $0.15 | $0.20 | $0.24 | — |
| Free cash flow | $2.15B | $267M | $1.17B | $1.55B | $2.81B | $629M |
| Gross margin | 41.1% | 40.2% | 42.4% | 43.6% | 47.3% | — |
| Net margin | 11.2% | 6.6% | 4.3% | 5.4% | 6.3% | 5.7% |
| Revenue growth | +10.1% | +11.5% | -1.3% | -1.8% | +2.9% | — |
| Cash + short-term investments | $4.54B | $3.31B | $2.74B | $3.17B | $4.53B | — |
| Total debt | $1.10B | $1.28B | $2.49B | $2.45B | $2.47B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CTVA)
P/E at fiscal year-ends: Dec 2025 41.7x, Dec 2024 43.7x, Dec 2023 46.4x.
Superinvestors (SEC 13F-HR, Q2 2026) (CTVA)
2 of 80 tracked investors hold CTVA. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Bill Nygren | Oakmark Funds | 1.84% | $1.38B | Reduced -1.9% |
| Dodge & Cox Funds | Dodge & Cox | <0.01% | $1.7M | Reduced -0.7% |
Analysts (CTVA)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | UBS | Target lowered | Neutral | $90 → $15 |
| 2026-10-07 | Keybanc | Upgrade | Sector Weight → Overweight | $17 |
| 2026-10-06 | JP Morgan | Upgrade | Neutral → Overweight | $83 → $19 |
| 2026-09-18 | Argus Research | Reiterated | Buy | $91 |
| 2026-09-17 | Citigroup | Target raised | Neutral | $86 → $91 |
| 2026-09-16 | BMO Capital | Target lowered | Outperform | $100 → $95 |
| 2026-09-16 | UBS | Target raised | Neutral | $85 → $90 |
| 2026-09-16 | RBC Capital | Reiterated | Outperform | $103 |
| 2026-09-11 | Keybanc | Initiated | Sector Weight | |
| 2026-08-18 | UBS | Target lowered | Neutral | $89 → $85 |
| 2026-08-03 | UBS | Target raised | Neutral | $86 → $89 |
| 2026-08-03 | Citigroup | Target raised | Neutral | $85 → $86 |
Total return (dividends reinvested) (CTVA)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +36.3% | +111.5% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +36.4% | +16.1% |
| Volatility (annualized) | 30.6% | 27.0% |
| Max drawdown | -16.6% (Jul 2026→Aug 2026) | -34.8% (Nov 2022→Nov 2023) |
Companies that name CTVA in their SEC reports
| Relationship to CTVA | Company | Filing | Sentence |
|---|---|---|---|
| partner | Evogene Ltd. (EVGN) | 20-F Mar 26, 2026 | “Under the terms of the collaboration agreement, AgPlenus and Corteva” |
| partner | Qnity Electronics, Inc. (Q) | 10-K Feb 26, 2026 | “In connection with their separation, DuPont entered into a letter agreement with Corteva (the "Corteva Letter Agreement") that imposes limitations intended to preserve the agreed allocation of certain legacy liabilities among the parties following the separation.” |
| partner | DuPont de Nemours, Inc. (DD) | 10-K Feb 17, 2026 | “4.Primarily related to the DWDP Separation and Distribution Agreement and Letter Agreement between Corteva and EIDP and the Electronics Separation and Distribution Agreement with Qnity.” |
CTVA analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.11 | $0.00 | — | $1.76B | 5 |
| Next quarter (ends Dec 2026) | $0.27 | $0.00 | — | $2.31B | 4 |
| Current fiscal year (ends Dec 2026) | $1.11 | $0.00 | — | $7.82B | 7 |
| Next fiscal year (ends Dec 2027) | $1.13 | $0.00 | — | $8.06B | 8 |
CTVA options: expected move
Options price a move of about ±11.1% (±$1.42) by Nov 20, 2026, which includes earnings on Nov 11, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 48.8% | ±11.1% |
| Dec 18, 2026 | 56 | 47.5% | ±15.1% |
| Mar 19, 2027 | 147 | 43.4% | ±21.9% |
| Jun 17, 2027 | 237 | 60.5% | ±37.7% |
30-day implied volatility 47.3% vs 54.2% realized over the last 30 trading days. Put/call ratio (volume) 2.11. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 12.86 |
|---|---|
| Change | ▲ 1.10% (up) |
| Previous Close | USD 12.86 |
| Open | USD 12.86 |
| Day Range | USD 12.52 – 12.89 |
| 52-Week Range | USD 9.08 – 14.62 |
| Volume | 16,000,948 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (CTVA)
Nexqual's technical model rates CTVA "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 48.49 (neutral) |
| vs SMA50 | Above (USD 12.52) |
| MACD | 0.13 (positive) |
Earnings (CTVA)
| Next Earnings Date | 2026-11-11 |
|---|---|
| EPS Estimate | USD 0.11 |
| Revenue Estimate | $1.76B |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (CTVA)
| Total Revenue | $4.97B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -1.20% |
| Gross Margin | +33.21% |
| Operating Margin | +12.78% |
| Profit Margin | +2.76% |
| Debt / Equity | 0.57 |
| Current Ratio | 1.79 |
| Total Cash | $1.90B |
| Total Debt | $4.77B |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Ownership (CTVA)
| Insider Ownership | +0.16% |
|---|---|
| Institutional Ownership | +92.09% |
| Shares Outstanding | 667.20M |
| Float | 666.78M |
| Short % of Float | +3.69% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MOS | Mosaic Company (The) | USD 17.27 | ▼ 2.32% |
| CF | CF Industries Holdings, Inc. | USD 118.56 | ▲ 1.94% |
| SMG | Scotts Miracle-Gro Company (The | USD 59.15 | ▲ 5.76% |
| NTR | Nutrien Ltd. | USD 69.09 | ▲ 1.42% |
| FMC | FMC Corporation | USD 5.02 | ▼ 0.2% |
| IPI | Intrepid Potash, Inc | USD 30.77 | ▼ 1.38% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt